Investors | Shareholder information
Shareholder Meeting Notices
Date Title Document Webcast
21/05/2015 Notice of 2015 AGM
11/05/2016 Notice of 2016 AGM
12/10/2016 Notice of General Meeting to be held on 28 October 2016
  • Placing, Open Offer and Notice of GM Circular
  • EGM Proxy Form
Share Detail
Number of shares 48,699,456
Country of listing UK / US
Status AIM Listed / NASDAQ Listed
Index FTSE AIM All Share / NASDAQ
FTSE Sector Pharmaceutical & Biotechnology
FTSE sub-sector Biotechnology
Ticker MTPH / MTP

The percentage of 0.005p Ordinary shares not being held in public hands is 63.3%

Shares held in treasury: Nil 0.005p Ordinary shares.

There are no restrictions on the transfer of Ordinary shares in the Company.

Information correct as at 31 October 2016

Major shareholders
Midatech Pharma has been notified or is aware of the following holdings of more than 3% or more of the issued share capital of the Company.
Name Number of shares %
Woodford Investment Management 9,867,629 20.3
Legal & General Group


Ferracom Establishment 3,043,164 6.2
Hargreave Hale 2,987,585 6.1
City Financial 2,000,000 4.1
Ippon Capital SA 1,649,334 3.4
Disruptive Capital Finance LLP 1,618,811 3.3

Information correct as at 03 January 2017

ADR Information
Ticker Structure Exchange Ratio DR ISIN CUSIP
MTP Level III ADR NASDAQ 1 ADR : 2 Ordinary Shares US59564R1041 59564R104
Shareholder information
© Copyright 2017 Midatech Pharma PLC